Jan 27, 2021, 01:00 by admin admin

New guidelines endorsed by more than 30 leading health groups, including the American Medical Association, call for focus on addiction treatment and prevention, avoid diversion of funds to close budget gaps.

Jan 26, 2021, 01:00 by admin admin

Treatment professional and addiction-related advocacy groups urge Congress to eliminate the X-waiver, which creates an unnecessary barrier to prescribing buprenorphine, and to prioritize education for addiction treatment.

Jan 21, 2021, 01:00 by admin admin

The Minnesota Society of Addiction Medicine (MNSAM) submitted a letter of support for SF61/HF19, companion bills which would remove the “buy and bill” requirement from all practitioner administered medications for substance use disorders (SUD).

Jan 8, 2021, 01:00 by admin admin

ASAM released its 2020 Advocacy Year in Review, which provides an overview of some of the new policies and resources that ASAM and its State Chapters helped advance in 2020, by working closely with federal and state policy-makers and other key stakeholders.

Jan 6, 2021, 01:00 by admin admin

The Kentucky Society of Addiction Medicine (KYSAM) sent a letter to the Kentucky Board of Nursing, expressing KYSAM’s strong support for the Advanced Practice Registered Nurse (APRN) Council’s recommended amendments to Kentucky’s professional standards for Kentucky APRNs who prescribe buprenorphine for the treatment of opioid use disorder (OUD). With the opioid addiction and overdose epidemic significantly impacting the country and Kentucky, KYSAM greatly appreciated the APRN Council’s efforts to increase access to evidence-based OUD treatment and encouraged the Kentucky Board of Nursing to adopt the APRN Council’s recommendations.

Jan 4, 2021, 01:00 by admin admin

The American Society of Addiction Medicine (ASAM), sent a letter to provide comments on the Interim Final Rule on the Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment (the “Interim Final Rule”).

Dec 22, 2020, 01:00 by admin admin

Today the American Society of Addiction Medicine (ASAM) commended Congress for yesterday’s passage of several important addiction-related provisions in its bipartisan, end-of-year spending package that will increase Americans’ access to addiction treatment.

Dec 2, 2020, 01:00 by admin admin

The office of the Inspector General at HHS released rules which shows they are not expanding the patient engagement and support safe harbor to include cash and cash-equivalent payments offered as part of contingency management interventions or other programs to motivate beneficial behavioral changes.

Nov 30, 2020, 01:00 by admin admin

ASAM sent a letter to congressional leadership opposing the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2019, which would, among other things, completely remove cannabis from the list of scheduled substances under the Controlled Substances Act (CSA).

Nov 9, 2020, 01:00 by admin admin

ASAM congratulates President-elect Joe Biden and Vice President-elect Kamala Harris on their projected historic victory.

Nov 9, 2020, 01:00 by admin admin

ASAM, the Campaign for Tobacco-Free Kids, and 67 partner organizations sent a letter to Food and Drug Administration (FDA) Commissioner Stephen Hahn urging him to commence rulemaking to prohibit menthol as a characterizing flavor in cigarettes.

Nov 3, 2020, 01:00 by admin admin

The Oregon Society of Addiction Medicine (ORSAM), Oregon Recovers, and nine other organizations sent a letter to Governor Kate Brown in support of raising beer and wine taxes in the state and using that revenue to make significant investments in addiction prevention, treatment and recovery services.

Oct 28, 2020, 01:00 by admin admin

The U.S. Department of Health and Human Services (HHS) has announced the allocation of up to $20 billion from the Provider Relief Fund (PRF) in the Phase 3 General Distribution.

Oct 14, 2020, 01:00 by admin admin

ASAM sent a letter to Senators Diane Feinstein (D-CA) and Chuck Grassley (R-IA) thanking them for their introduction of S. 4612, the Methamphetamine Response Act, which would declare methamphetamine an emerging drug threat.

Oct 13, 2020, 01:00 by admin admin

ASAM issued new policy recommendations to protect public health and mitigate the risks of cannabis use.

Oct 5, 2020, 01:00 by admin admin

ASAM's response encouraged CMS to consider the financial impact of new requirements on small practices that do not yet have the requisite electronic systems in place.

Oct 5, 2020, 01:00 by admin admin

ASAM’s comments stressed the importance of the Centers for Medicare and Medicaid Services altering the Medicare Physician Fee Schedule to expand access to treatment for beneficiaries suffering from substance use disorder.

Oct 2, 2020, 01:00 by admin admin

ASAM urges the Senate to pass a package that includes key provisions to preserve and expand access to addiction treatment.

Sep 30, 2020, 01:00 by admin admin

The American Society of Addiction Medicine sent a letter to Senators Pat Toomey and Joe Manchin and Representatives Harley Rouda and Markwayne Mullin thanking them for sponsoring the Improving Medicaid Programs’ Response to Overdose Victims and Enhancing (IMPROVE) Addiction Care Act.

Sep 22, 2020, 01:00 by admin admin

The Mental Health Liaison Group, of which ASAM is a member, sent a letter to Senators Tim Kaine (D-VA), Bill Cassidy (R-LA), Jack Reed (D-RI), and Todd Young (R-IN) thanking them for introducing the Dr. Lorna Breen Health Care Provider Protection Act (S.4349).